The Shocking Revelation of Quinoxalin-6-amine

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 6298-37-9

New Advances in Chemical Research, May 2021. The dynamic chemical diversity of the numerous elements, ions and molecules that constitute the basis of life provides wide challenges and opportunities for research. Recommanded Product: Quinoxalin-6-amine, We’ll be discussing some of the latest developments in chemical about CAS: 6298-37-9, name is Quinoxalin-6-amine. In an article,Which mentioned a new discovery about 6298-37-9

Parkinson’s disease (PD) is a chronic degenerative disorder characterized by typical motor symptoms caused by the death of dopamine (DA) neurons in the midbrain and ensuing shortage of DA in the striatum, at the level of nerve terminals. No curative treatment is presently available for PD in clinical practice. In our search for neuroprotectants in PD, we generated new 1,4,8-triazaphenanthrenes by combining 6-endo-dig-cycloisomerization of propargylquinoxalines and Suzuki or Sonogashira cross-coupling reactions. Neuroprotection assessment of newly synthesized 1,4,8-triazaphenanthrenes in a PD cellular model resulted in the discovery of a new hit compound PPQ (5m). Neuroprotection by 5m was concentration-dependent and the result of a combined effect on intracellular calcium release channels and astroglial cells. Of interest, 5m also counteracted DA cell loss in a mouse model of PD, making this molecule a promising candidate for PD treatment.

Do you like my blog? If you like, you can also browse other articles about this kind. Thanks for taking the time to read the blog about 6298-37-9

Reference:
Quinoxaline – Wikipedia,
Quinoxaline | C8H6N90 | ChemSpider